Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy

L Hol, ME Van Leerdam, M Van Ballegooijen… - Gut, 2010 - gut.bmj.com
Background: Screening for colorectal cancer (CRC) is widely accepted, but there is no
consensus on the preferred strategy. We conducted a randomised trial comparing …

[HTML][HTML] Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels

L Hol, JA Wilschut, M van Ballegooijen… - British journal of …, 2009 - nature.com
Immunochemical faecal occult blood testing (FIT) provides quantitative test results, which
allows optimisation of the cut-off value for follow-up colonoscopy. We conducted a …

Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening

EW De Bekker‐Grob, L Hol, B Donkers… - Value in …, 2010 - Wiley Online Library
ABSTRACT Objectives: Discrete choice experiments (DCEs) in health economics commonly
present choice sets in an unlabeled form. Labeled choice sets are less abstract and may …

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening

JA Wilschut, L Hol, E Dekker, JB Jansen… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Two European randomized trials (N= 30,000) compared guaiac
fecal occult blood testing with quantitative fecal immunochemical testing (FIT) and showed …

Attendance and yield over three rounds of population-based fecal immunochemical test screening

A Kapidzic, EJ Grobbee, L Hol… - Official journal of the …, 2014 - journals.lww.com
OBJECTIVES: Fecal immunochemical test (FIT) screening for colorectal cancer (CRC)
requires timely successive rounds for an optimal preventive effect. However, data on …

Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance

AHC van Roon, JA Wilschut, L Hol… - Clinical …, 2011 - Elsevier
BACKGROUND & AIMS: The fecal immunochemical test (FIT) is superior to the guaiac-
based fecal occult blood test in detecting neoplasia. There are not much data on the optimal …

Fecal occult blood testing when colonoscopy capacity is limited

JA Wilschut, JDF Habbema… - Journal of the …, 2011 - academic.oup.com
Background Fecal occult blood testing (FOBT) can be adapted to a limited colonoscopy
capacity by narrowing the age range or extending the screening interval, by using a more …

[HTML][HTML] Preferences for colorectal cancer screening strategies: a discrete choice experiment

L Hol, EW de Bekker-Grob, L van Dam… - British journal of …, 2010 - nature.com
Background: Guidelines underline the role of individual preferences in the selection of a
screening test, as insufficient evidence is available to recommend one screening test over …

18F-fludeoxyglucose–positron emission tomography/computed tomography and laparoscopy for staging of locally advanced gastric cancer: a multicenter prospective …

EC Gertsen, HJF Brenkman, R Van Hillegersberg… - JAMA …, 2021 - jamanetwork.com
Importance The optimal staging for gastric cancer remains a matter of debate. Objective To
evaluate the value of 18 F-fludeoxyglucose–positron emission tomography with computed …

What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment

L van Dam, L Hol, EW de Bekker-Grob… - European journal of …, 2010 - Elsevier
INTRODUCTION: In many countries uptake of colorectal cancer (CRC) screening remains
low. AIM: To assess how procedural characteristics of CRC screening programmes …